Literature DB >> 10885769

Human trials of HIV-1 vaccines.

M J Mulligan1, J Weber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10885769

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

1.  Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques.

Authors:  D C Montefiori; J T Safrit; S L Lydy; A P Barry; M Bilska; H T Vo; M Klein; J Tartaglia; H L Robinson; B Rovinski
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.

Authors:  R A Kaslow; C Rivers; J Tang; T J Bender; P A Goepfert; R El Habib; K Weinhold; M J Mulligan
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1.

Authors:  Shixia Wang; James Arthos; John M Lawrence; Donald Van Ryk; Innocent Mboudjeka; Siyuan Shen; Te-Hui W Chou; David C Montefiori; Shan Lu
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapy.

Authors:  Xia Jin; Murugappan Ramanathan; Shady Barsoum; Geoffrey R Deschenes; Lei Ba; James Binley; Daryl Schiller; Daniel E Bauer; Donald C Chen; Arlene Hurley; Lucette Gebuhrer; Raphaelle El Habib; Pierre Caudrelier; Michel Klein; Linqi Zhang; David D Ho; Martin Markowitz
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa.

Authors:  Renata Bures; Lynn Morris; Carolyn Williamson; Gita Ramjee; Mark Deers; Susan A Fiscus; Salim Abdool-Karim; David C Montefiori
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma.

Authors:  Bradley H Edwards; Anju Bansal; Steffanie Sabbaj; Janna Bakari; Mark J Mulligan; Paul A Goepfert
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.